Pohang, South Korea

Ki-Su Kim


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ki-Su Kim: Innovator in Nucleic Acid Delivery Systems

Introduction

Ki-Su Kim is a prominent inventor based in Pohang, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for nucleic acids. His work focuses on enhancing the efficiency of nucleic acid delivery, which is crucial for various therapeutic applications.

Latest Patents

Ki-Su Kim holds a patent for a "Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid." This invention relates to a delivery system for nucleic acids using a cationic polymer conjugate. Specifically, it involves a delivery system that comprises a cationic polymer conjugate prepared by conjugating hyaluronic acid or its derivative with polyethyleneimine. The system is designed to facilitate the delivery of nucleic acids into mammalian cells through electrostatic binding with the cationic polymer conjugate.

Career Highlights

Throughout his career, Ki-Su Kim has been associated with notable institutions that focus on research and development. He has worked with the Postech Academy-Industry Foundation and the Korea University Industry and Academy Collaboration Foundation. His contributions in these roles have helped advance the field of biotechnology and foster collaboration between academia and industry.

Collaborations

Ki-Su Kim has collaborated with several esteemed colleagues, including Yu-Kyoung Oh and Hyun-Gu Kang. These collaborations have played a vital role in enhancing the research and development of innovative solutions in the field of nucleic acid delivery.

Conclusion

Ki-Su Kim is a distinguished inventor whose work in nucleic acid delivery systems has the potential to impact therapeutic applications significantly. His innovative approach and collaborations with leading institutions highlight his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…